✦ LIBER ✦

Etoposide + cyclophosphamide: more efficient stem cell mobilisation

Book ID: 120861706
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213610-00036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, epirubicin, and etoposide (I

Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide

✍ Christina Hart; Christian Blank; Stefan W. Krause; Reinhard Andreesen; Burkhard 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 136 KB

Stem cell mobilisation with cyclophospha

Stem cell mobilisation with cyclophosphamide - what dose?

✍ KOTASEK, D. ;DALE, B. M. ;NORMAN, J. E. ;SAGEy, R. E. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Dexamethasone, paclitaxel, etoposide, cy

Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma

✍ Bilgrami, S; Bona, R D; Edwards, R L; Li, Z; Naqvi, B; Shaikh, A; Furlong, F; Fo 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

IVE (ifosfamide, epirubicin and etoposid

IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma

✍ C. P. Fox; A. K. McMillan; M. J. Bishton; A. P. Haynes; N. H. Russell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Busulfan, cyclophosphamide, and etoposid

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

✍ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel

Cyclophosphamide, etoposide and G-CSF to

Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma

✍ Mollee, P; Pereira, D; Nagy, T; Song, K; Saragosa, R; Keating, A; Crump, M 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB